Cargando…
Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis
BACKGROUND: Recent studies demonstrated that engagement of sodium glucose transporter 1 (SGLT-1) by orally administered D-glucose protects the intestinal mucosa from lipopolysaccharide (LPS)-induced injury. We tested whether SGLT-1 engagement might protect the intestinal mucosa from doxorubicin (DXR...
Autores principales: | Cardani, Diego, Sardi, Claudia, La Ferla, Barbara, D’Orazio, Giuseppe, Sommariva, Michele, Marcucci, Fabrizio, Olivero, Daniela, Tagliabue, Elda, Koepsell, Hermann, Nicotra, Francesco, Balsari, Andrea, Rumio, Cristiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937063/ https://www.ncbi.nlm.nih.gov/pubmed/24495286 http://dx.doi.org/10.1186/1476-4598-13-23 |
Ejemplares similares
-
Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate “altered” cells?
por: Sommariva, Michele, et al.
Publicado: (2012) -
How Tumor Cells Choose Between Epithelial-Mesenchymal Transition and Autophagy to Resist Stress—Therapeutic Implications
por: Marcucci, Fabrizio, et al.
Publicado: (2018) -
Depleting Tumor Cells Expressing Immune Checkpoint Ligands—A New Approach to Combat Cancer
por: Marcucci, Fabrizio, et al.
Publicado: (2021) -
Glycolysis-induced drug resistance in tumors—A response to danger signals?
por: Marcucci, Fabrizio, et al.
Publicado: (2021) -
Tumor Cell Glycolysis—At the Crossroad of Epithelial–Mesenchymal Transition and Autophagy
por: Marcucci, Fabrizio, et al.
Publicado: (2022)